Institutional Ownership Pmv Pharmaceuticals, Inc. (PMVP)
This table provides information about the institutional ownership of Pmv Pharmaceuticals, Inc. (PMVP). We have compiled data on the 61 institutions that hold shares in the stock, with a total of 37.6 Million shares, which have been reported (via 13F filing form) to have a value of $52.6 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
6,475,291
shares
|
$10.4 Million
0.25% of portfolio
|
Q4 2023
Reduced 1.34%
|
|
Bml Capital Management, LLC
Zionsville, IN |
Aug 11, 2025 Q2 2025 |
5,000,000
shares
|
$8 Million
4.01% of portfolio
|
Q2 2025
Added 33.42%
|
|
Sio Capital Management, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
3,735,396
shares
|
$5.98 Million
1.89% of portfolio
|
Q1 2025
Added 4.57%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Aug 14, 2025 Q2 2025 |
3,188,116
shares
|
$5.1 Million
0.07% of portfolio
|
Q2 2025
Reduced 3.64%
|
|
Euclidean Capital LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,627,643
shares
|
$4.2 Million
0.92% of portfolio
|
Q3 2023
Added 3.24%
|
|
Alkeon Capital Management LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
2,342,373
shares
|
$3.75 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.06%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
2,153,600
shares
|
$3.45 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.99%
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
2,066,137
shares
|
$3.31 Million
0.0% of portfolio
|
Q2 2025
Added 0.93%
|
|
Interwest Venture Management CO
|
Oct 20, 2023 Q3 2023 |
1,614,911
shares
|
$2.58 Million
48.05% of portfolio
|
Q2 2022
Reduced 50.08%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,162,193
shares
|
$1.86 Million
0.0% of portfolio
|
Q2 2024
Reduced 62.63%
|
|
Oup Management Co., LLC
|
Nov 09, 2023 Q3 2023 |
989,232
shares
|
$1.58 Million
13.66% of portfolio
|
Q4 2021
New holding
|
|
Stonepine Capital Management, LLC
Bend, OR |
Aug 13, 2025 Q2 2025 |
845,968
shares
|
$1.35 Million
0.88% of portfolio
|
Q2 2025
Added 34.24%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
647,629
shares
|
$1.04 Million
0.0% of portfolio
|
Q2 2025
Reduced 31.81%
|
|
Aldebaran Capital, LLC
Indianapolis, IN |
Aug 12, 2025 Q2 2025 |
515,128
shares
|
$824,204
0.54% of portfolio
|
Q2 2025
Reduced 1.61%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
485,700
shares
|
$777,120
0.0% of portfolio
|
Q2 2025
Reduced 3.94%
|
|
Peapod Lane Capital LLC
Bedford Hills, NY |
Jul 31, 2025 Q2 2025 |
452,682
shares
|
$724,291
0.48% of portfolio
|
Q2 2025
Reduced 7.5%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
432,704
shares
|
$692,326
0.0% of portfolio
|
Q2 2025
Added 0.44%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
291,455
shares
|
$466,328
0.0% of portfolio
|
Q2 2025
Reduced 17.49%
|
|
Monarch Partners Asset Management LLC
|
Feb 02, 2023 Q4 2022 |
263,449
shares
|
$421,518
0.7% of portfolio
|
Q4 2022
Added 25.23%
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
263,059
shares
|
$420,894
0.0% of portfolio
|
Q2 2025
Added 128.67%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
256,431
shares
|
$410,289
0.0% of portfolio
|
Q2 2025
Added 1716.08%
|
|
Rbf Capital, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
245,561
shares
|
$392,897
0.01% of portfolio
|
Q4 2024
Reduced 3.08%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
157,578
shares
|
$252,124
0.0% of portfolio
|
Q4 2024
Added 8.62%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
148,800
shares
|
$238,080
0.0% of portfolio
|
Q1 2025
Reduced 26.37%
|
|
Evoke Wealth, LLC
|
Aug 07, 2025 Q2 2025 |
133,122
shares
|
$212,995
0.0% of portfolio
|
Q3 2024
Added 110.53%
|